Изучение различных диетических вмешательств у пациентов с артериальной гипертонией и метаболическим синдромом

Ожирение является независимым фактором риска сердечно-сосудистых заболеваний (ССЗ), сахарного диабета 2 типа и артериальной гипертензии (АГ). Оптимизация методов борьбы с ССЗ — одна из самых актуальных и неотложных проблем для России. Многие исследования показали, что масса тела коррелирует с АД, и данная взаимосвязь обусловлена сложными патогенетическими механизмами. В связи с чем терапевтические подходы у пациента с ожирением, метаболическим синдромом и АГ требуют учета всех патофизиологических изменений, связанных с данными заболеваниями. Нефармакологические методы лечения, такие как изменение образа жизни, включая снижение веса, соблюдение диетических рекомендаций и увеличение физической активности, может напрямую влиять на уровни АД и улучшать контроль АД. Широкий спектр диетологических вмешательств эффективен при лечении ожирения и сопутствующих заболеваний, врачи должны учитывать все варианты и проводить персонализированные вмешательства. Средиземноморская диета, вегетарианские диеты, DASH диета, нордическая диета и низкоуглеводная диета – все они были связаны с улучшением метаболического здоровья с изменениями массы тела или без них. Последние данные еще больше усиливают роль добавок пищевых

волокон к ежедневному рациону у больных с АГ и метаболическим синдромом, хотя не было обнаружено доказательств значительного их преимущества. С учетом национальных пищевых особенностей нами предложено исследование, в котором планируется изучить влияние русской диеты с добавлением клетчатки на метаболические показатели у пациентов с АГ. Планируется оценить влияние диетотерапии на показатели нарушения обмена кишечных метаболитов.

1. Liang X, Su S, Hao G et al. Determinants of pulse wave velocity trajectories from youth to young adulthood: the Georgia Stress and Heart Study. Am J Hypertens. 2019;37(3):563. https://doi.org/10.1097/hjh.0000000000001933

2. Arauz-Pacheco C, Parrott MA, Raskin P. American Diabetes Association. Hypertension management in adults with diabetes. Diabetes Care. 2004;27(Suppl 1):S65-S67. https://doi.org/10.2337/diacare.27.2007.S65

3. Landsberg L, Aronne LJ, Beilin LJ et al. Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment: a position paper of The Obesity Society and the American Society of Hypertension. J Clin Hypertens (Greenwich). 2013 Jan;15(1):14-33. https://doi.org/10.1111/jch.12049

4. Баланова ЮА, Шальнова СА, Имаева АЭ и др. ЭССЕ-РФ-2. Распространенность артериальной гипертонии, охват лечением и его эффективность в Российской Федерации (данные наблюдательного исследования ЭССЕ-РФ-2). Рациональная Фармакотерапия в Кардиологии 2019;15(4):450-466. https://doi.org/10.20996/1819-6446-2019-15-4-450-466

5. Centers for Disease Control and Prevention. National Diabetes Statistics Report. Estimates of Diabetes and its Burden in the United States. Updated Jun 29 2022. Accessed Mar 2, 2023.

6. Stierman B, Afful J, Carroll MD et al. National Health and Nutrition Examination Survey 2017–March 2020 prepandemic data files - development of files and prevalence estimates for selected health outcomes. National Health Statistics Reports. 2021. Accessed Mar 2, 2023. https://doi.org/10.15620/cdc:106273

7. Kannel WB, Brand N, Skinner JJ et al. The relation of adiposity to blood pressure and development of hypertension. The Framingham study. Ann Intern Med. 1967;67:48-59. https://doi.org/10.7326/0003-4819-67-1-48

8. Vasan RS, Beiser A, Seshadri S et al. Residual lifetime risk for developing hypertension in middleaged women and men: The Framingham Heart Study. JAMA 2002;287(8):1003–10. https://doi.org/10.1001/jama.287.8.1003

9. Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr. 1956;4:20-34. https://doi.org/10.1093/ajcn/4.1.20

10. Krotkiewski M, Bjorntorp P, Sjostrom L et al. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest. 1983;72:1150-62. https://doi.org/10.1172/JCI111040

11. Kalkhoff RK, Hartz AH, Rupley D et al. Relationship of body fat distribution to blood pressure, carbohydrate tolerance, and plasma lipids in healthy obese women. J Lab Clin Med. 1983;102:621-7. PMID: 6352839

12. Lapidus L, Bengtsson C, Larsson B et al. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J (Clin Res Ed). 1984;289:1257-61. https://doi.org/10.1136/bmj.289.6454.1257

13. Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Bjorntorp P, Tibblin G. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J (Clin Res Ed). 1984;288:1401-4. https://doi.org/10.1136/bmj.288.6428.1401

14. Scherrer U, Randin D, Tappy L et al. Body fat and sympathetic nerve activity in healthy subjects. Circulation. 1994;89:2634-40. https://doi.org/10.1161/01.cir.89.6.2634

15. Grassi G, Seravalle G, Colombo M et al. Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans. Circulation. 1998;97:2037-42. https://doi.org/10.1161/01.cir.97.20.2037

16. Kennedy A, Gettys TW, Watson P et al. The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. Journal of Clinical Endocrinology and Metabolism. 1997;82:1293-300. https://doi.org/10.1210/jcem.82.4.3859

17. Kazumi T, Kawaguchi A, Katoh J et al. Fasting insulin and leptin serum levels are associated with systolic blood pressure independent of percentage body fat and body mass index. Journal of Hypertension. 1999;17:1451-5. https://doi.org/10.1097/00004872-199917100-00013

18. Sarzani R, Salvi F, Dessi-Fulgheri P et al. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. Journal of Hypertension.2008;26:831-43. https://doi.org/10.1097/HJH.0b013e3282f624a0

19. Ahmed SB, Fisher ND, Stevanovic R et al. Body mass index and angiotensin-dependent control of the renal circulation in healthy humans. Hypertension. 2005;46:1316-20. https://doi.org/10.1161/01.HYP.0000190819.07663.da

20. Adamczak M, Wiecek A, Funahashi T et al. Decreased plasma adiponectin concentration in patients with essential hypertension. American Journal of Hypertension. 2003;16:72-5. https://doi.org/10.1016/s0895-7061(02)03197-7

21. Silverman BL, Landsberg L, Metzger BE. Fetal hyperinsulinism in offspring of diabetic mothers. Association with the subsequent development of childhood obesity. Annals of the New York Academy of Sciences. 1993;699:36-45. https://doi.org/10.1111/j.1749-6632.1993.tb18835.x

22. Hausberg M, Barenbrock M, Kosch M. Elevated sympathetic nerve activity: the link between low birth size and adult-onset metabolic syndrome? Journal of Hypertension. 2004;22:1087-9. https://doi.org/10.1097/00004872-200406000-00006

23. Caballero AE. Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease. Obesity Research. 2003;11:1278-89. https://doi.org/10.1038/oby.2003.174

24. Eckel RH, Jakicic JM, Ard JD et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Assocation Task Force on Practice Guidelines [published correction appears in Circulation. 2014; 129(25 Suppl 2): S100-S101]. Circulation. 2014;129(25 Suppl2):S76-S99. https://doi.org/10.1161/01.cir.0000437740.48606.d1

25. LeFevre ML; U.S. Preventive Services Task Force. Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2014;161(8):587-593. https://doi.org/10.7326/M14-1796

26. Keys, A. Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease. Cambridge, MA: Harvard University Press, 1980. https://doi.org/10.4159/harvard.9780674497887

27. Willett WC. The Mediterranean diet: science and practice. Public Health Nutr. 2006 Feb;9(1A):105-10. https://doi.org/10.1079/phn2005931

28. Appel LJ, Sacks FM, Carey VJ et al. OmniHeart Collaborative Research Group. Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA 2005; 294(19):2455–64. https://doi.org/10.1001/jama.294.19.2455

29. Berild A, Holven KB, Ulven SM. Recommended Nordic diet and risk markers for cardiovascular disease. Tidsskr Nor Laegeforen. 2017 May 23;137(10):721-726. English, Norwegian. https://doi.org/10.4045/tidsskr.16.0243

30. Filippou CD, Tsioufis CP, Thomopoulos CG et al. Dietary Approaches to Stop Hypertension (DASH) Diet and Blood Pressure Reduction in Adults with and without Hypertension: A Systematic Review and MetaAnalysis of Randomized Controlled Trials. Adv Nutr. 2020 Sep 1;11(5):1150-1160. https://doi.org/10.1093/advances/nmaa041

31. Santos FL, Esteves SS, da Costa Pereira A et al. Systematic review and meta-analysis of clinical trials of the effects of low carbohydrate diets on cardiovascular risk factors. Obes Rev. 2012;13(11):1048-1066. https://doi.org/10.1111/j.1467-789X.2012.01021

32. Evert AB, Dennison M, Gardner CD et al. Nutrition therapy for adults with diabetes or prediabetes: a consensus report. Diabetes Care. 2019;42(5):731-754. https://doi.org/10.2337/dci19-0014

33. Saslow LR, Jones LM, Sen A et al. Comparing Very Low-Carbohydrate vs DASH Diets for Overweight or Obese Adults With Hypertension and Prediabetes or Type 2 Diabetes: A Randomized Trial. Ann Fam Med. 2023 May-Jun;21(3):256-263. https://doi.org/10.1370/afm.2968

34. Mozaffarian D, Fahimi S, Singh GM et al. Global Burden of Diseases Nutrition and Chronic Diseases Expert Group. Global sodium consumption and death from cardiovascular causes. N Engl J Med 2014;371(7):624– 34. https://doi.org/10.1056/NEJMoa1304127

35. John JH, Ziebland S, Yudkin P et al. Oxford Fruit and Vegetable Study Group. Effects of fruit and vegetable consumption on plasma antioxidant concentrations and blood pressure: a randomised controlled trial. Lancet 2002;359(9322):1969–74. https://doi.org/10.1016/s0140-6736(02)98858-6

36. Streppel MT, Arends LR, van ’t Veer P et al. Dietary Fiber and Blood Pressure: A Meta-analysis of Randomized Placebo-Controlled Trials. Arch Intern Med. 2005;165(2):150–156. https://doi.org/10.1001/archinte.165.2.150

37. Beilin LJ. Vegetarian and other complex diets, fats, fiber, and hypertension. Am J Clin Nutr. 1994 May;59(5 Suppl):1130S-1135S. https://doi.org/10.1093/ajcn/59.5.1130S

38. Streppel MT, Arends LR, van ’t Veer P, Grobbee DE, Geleijnse JM. Dietary Fiber and Blood Pressure: A Metaanalysis of Randomized Placebo-Controlled Trials. Arch Intern Med. 2005;165(2):150–156. https://doi.org/10.1001/archinte.165.2.150

39. Spiller A CRC Handbook of Dietary Fiber in Human Nutrition 3rd ed. Boca Raton, Fla CRC Press 2001.

40. Bessesen DH. The role of carbohydrates in insulin resistance. J Nutr. 2001 Oct;131(10):2782S-2786S. https://doi.org/10.1093/jn/131.10.2782S

41. Coudray C, Demigne C, Rayssiguier Y. Effects of dietary fibers on magnesium absorption in animals and humans. J Nutr. 2003 Jan;133(1):1-4. https://doi.org/10.1093/jn/133.1.1

42. Johnston BC, Kanters S, Bandayrel K et al.Comparison of weight loss among named diet programs in overweight and obese adults: A meta-analysis.JAMA. 2014;312:923-933. https://doi.org/10.1001/jama.2014.10397

43. Redman LM, Heilbronn LK, Martin CK et al. Pennington CALERIE Team. Metabolic and behavioral compensations in response to caloric restriction: implications for the maintenance of weight loss. PLoS One. 2009;4(2):e4377. https://doi.org/10.1371/journal.pone.0004377

44. Чазова И.Е., Шестакова М.В., Жернакова Ю.В., Маркова Т.Н. и соавт. Российское медицинское общество по артериальной гипертонии. Рекомендации по ведению больных артериальной гипертонией с метаболическими нарушениями и сахарным диабетом 2-го типа. Системные гипертензии 2020;17(1):7-45. https://doi.org/10.26442/2075082X.2020.1.200051

45. Fardet L, Flahault A, Kettaneh A et al. Corticothérapie systémique et alimentation: suivi des recommandations diététiques et relation entre apports alimentaires et apparition d'une lipodystrophie [Systemic corticosteroid therapy: patients' adherence to dietary advice and relationship between food intake and corticosteroid-induced lipodystrophy]. Rev Med Interne. 2007 May;28(5):284-8. French. https://doi.org/10.1016/j.revmed.2006.12.013

46. Timko CA, Perone J. Rigid and flexible control of eating behavior in a college population. Eating behaviors 2005;6(2):119–25. https://doi.org/10.1016/j.eatbeh.2004.09.002